A Newly Developed Artificial Chemical Receptor Will Help Viral Transduction for T-Cell Engineering Medicine & Technology Apr 13, 2019 Chimeric antigen receptor T cell (CAR-T) otherwise known as engineering T cell immunotherapy and T cell receptor T cell (TCR-T) has emerged as a viable therapeutic strategy for treating tumors.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts